Pharmaprocess
Innovation Forum in Pharmaceutical Process
To increase efficiency and optimise manu-
facturing processes in the pharmaceutical
industry; and to achieve greater involve-
ment by the entire sector to combat
counterfeit medicines; these were two of
the main needs identified in the conclu-
sions from the second Pharmaprocess
Forum, held at the Congress Palace.
In his opening speech, Doctor Manel
Esteller, director of Cancer Epigenetics
and Biology at Bellvitge Biomedical Re-
search Institute (IDIBELL) and one of the
most prestigious researchers in the fight
against this illness, called for an increase
in cooperation between academic re-
search, medical centres and the industry
in order to ensure that new discoveries
are applied as soon as possible.
More than 68 national and international
speakers addressed some 300 congress
attendees at the Pharmaprocess Forum.
The commercial zone, occupied by more
than 40 brands, was visited by over 1,500
professionals.
Edition
2nd
Area
3,700 m²
Exhibitors
43
Type
Professional
Activities
Seminars
Presentations
Montjuïc venue
27 28/October
300
attendees
The largest markets in the
pharmaceutical sector
are in emerging countries:
China, India and Brazil
92
Trade Shows
